Symbols

EVOK(Delisted)

Evoke Pharma·NASDAQ

--(--)

EVOK fundamentals

EVOK Q2 undefined Earnings

Evoke Pharma (EVOK) released its earnings on Aug 14, 2017: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.

Revenue / YoY

EPS / YoY

Report date

Aug 14, 2017

Earnings

EPS

Revenue

Revenue & Expenses

EVOK has released its 2025 Q3 earnings report, with revenue of 4.28M, reflecting a YoY change of 61.40%, and net profit of -1.16M, showing a YoY change of 11.90%. The Sankey diagram below clearly presents EVOK's revenue sources and cost distribution.

Key Indicators

Evoke Pharma (EVOK) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Evoke Pharma (EVOK)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Evoke Pharma (EVOK)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Evoke Pharma (EVOK)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown

Revenue Breakdown

Where does Evoke Pharma (EVOK) generate its revenue? Explore its key revenue streams and top earning regions.

By Business

Data source:

By Region

Data source:

Dividend

Track Evoke Pharma (EVOK) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History

Payout Ratio

Dividend Yield

You can ask Aime

No Data